Woodford Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,579,353
Closed -$113M 7
2017
Q4
$113M Sell
1,579,353
-86,239
-5% -$6.55M 7.63% 5
2017
Q3
$135M Sell
1,665,592
-554,508
-25% -$42.4M 6.19% 5
2017
Q2
$157M Buy
2,220,100
+632,000
+40% +$42.1M 5.77% 5
2017
Q1
$108M Buy
1,588,100
+973,800
+159% +$68.5M 4.47% 5
2016
Q4
$44M Buy
614,300
+127,500
+26% +$9.48M 2.12% 6
2016
Q3
$38.5M Buy
+486,800
New +$39.5M 1.56% 7

Other funds holding GILD

Woodford Investment Management's GILD Position: Q1 2018 in Review

Woodford Investment Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 1,579,353 shares — an estimated $113M sold.

Woodford Investment Management first reported a position in GILD in Q3 2016 and held it in 6 quarters. The position peaked at $157M in Q2 2017. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Woodford Investment Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Woodford Investment Management sold 1,579,353 Gilead Sciences shares in Q1 2018, an estimated $113M.
  • Woodford Investment Management first reported a position in Gilead Sciences in Q3 2016 and held it in 6 quarters.
  • Woodford Investment Management's Gilead Sciences position peaked at $157M in Q2 2017.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Woodford Investment Management's 13F filing for Q1 2018, filed 11 May 2018.